NCT00440128View on ClinicalTrials.gov

The Effects Of GW679769 (Casopitant) On The Pharmacokinetics Of Docetaxel In Subjects With Cancer

PHASE1CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

May 4, 2007

Primary Completion Date

July 17, 2008

Study Completion Date

July 17, 2008

Conditions

Nausea and Vomiting, Chemotherapy-Induced

Interventions

DRUG

Docetaxel

Docetaxel

DRUG

Casopitant/Docetaxel

Casopitant/Docetaxel

Trial Locations (4)

48201

GSK Investigational Site, Detroit

52242

GSK Investigational Site, Iowa City

71913

GSK Investigational Site, Hot Springs

03756

GSK Investigational Site, Lebanon

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY